Jagsonpal Pharmaceuticals Limited
Share Price Target & Analysis

NSE:JAGSNPHARM

VWAP

234.00

Open

235.02

Close

236.40

High

228.83

Low

328.04

52 Week High

232.95 ⇩
-2.07 (-0.88%)

JAGSNPHARM

(PHARMA)
51.9% Momentum

Turnaround Potential

130.48

52 Week Low

8.32

EPS

49.72

PE

3.3

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: JAGSNPHARM Share Price Financial Analysis & Valuation

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 423.1 (in Cr). Total number of free float shares are 2.6 (in Lacs). Jagsonpal Pharmaceuticals Limited is listed on NSE with Exchange ID - INE048B01035 and trading code is NSE:JAGSNPHARM with short name JagsonpalPharma.

In the past 1 year, Jagsonpal Pharmaceuticals Limited has declared an equity dividend of Rs 4 per share. At the current share price of JAGSNPHARM at Rs 232.95, this results in a dividend yield of 1.72 %.

As per the Fundamental Analysis of NSE:JAGSNPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine JAGSNPHARM underlying value and future prospects. All of this data is available in JAGSNPHARM financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:JAGSNPHARM, it is clearly understood that JAGSNPHARM is Economical performer in terms of earnings and profit margins with an EPS of 8.32. NSE:JAGSNPHARM book value per share as of today is 70.62. The current price to book ratio for JAGSNPHARM as of Jun 16, 2025 is 3.3.

Valuation of the Stock: The current valuation of JAGSNPHARM stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of JAGSNPHARM whether to BUY this stock at current valuation. The delivery percentage of JAGSNPHARM is 46.17% is very crucial parameter which shows that 46.17% investors are anticipating that the price of JAGSNPHARM share should go up with VWAP at .

Now, the main question is whether to BUY or SELL, NSE:JAGSNPHARM at current valuation.
As per latest Analysis No. #795:-

⇑ STRONG BUY JAGSNPHARM if All Greens

⇗ BUY JAGSNPHARM (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD JAGSNPHARM (With Stop Loss) if only 1 Green

⇘ SELL JAGSNPHARM if NO Green Indicator

NSE: JAGSNPHARM Share Price Today (Jun 16, 2025)

(Jagsonpal Pharmaceuticals Limited Daily Analysis on the basis of JAGSNPHARM Intraday Graph & Trend)

Jagsonpal Pharmaceuticals Limited share price moved Down by -0.88% from its previous close of Rs 235.02. JAGSNPHARM stock last traded price is 232.95. JAGSNPHARM share price trend is Down with a total of 103057 stocks traded till now. It has touched an intraday high of Rs 236.40 and an intraday low of Rs 228.83. The JAGSNPHARM trading at 232.95, Down by Rs. -2.07, or -0.88 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down.

NSE: JAGSNPHARM Share Price Tomorrow Prediction

(Jagsonpal Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of JAGSNPHARM)

Jagsonpal Pharmaceuticals Limited share price moved Down by -0.88%. JAGSNPHARM share price short term trend is Down. It suggests that JAGSNPHARM Share Price for Tomorrow remains the same with VWAP at will be treated as stop loss for intraday traders. Jagsonpal Pharmaceuticals Limited Long term investors can follow the JAGSNPHARM long term trend as mentiond in future forecast table.

NSE Code

NSE: JAGSNPHARM

JAGSNPHARM Share Price Today

 232.95

JAGSNPHARM Share Price Target Prediction for 2025 ^

 220.8 - 329.7

JAGSNPHARM Share Price Target Prediction for 2026*^

 329.7 - 351.2

JAGSNPHARM Share Price Target Prediction for 2027*^

 351.2 - 375.8

JAGSNPHARM Share Price Target Prediction for 2028*^

 395

JAGSNPHARM Share Price Target Prediction for 2029*^

 406

JAGSNPHARM Share Price Target Prediction for 2030*^

 442
JAGSNPHARM Current Book Value 2024
70.3

*Jagsonpal Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^JAGSNPHARM share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

JAGSNPHARM Technical Analysis

Candlestick Pattern: @222.03

JAGSNPHARM Moving Averages

BUY (5) NEUTRAL (0) SELL (9)
MA Simple Action S1 Expo Action E2
MA_5 219.44 BUY 219.42 BUY
MA_12 228.66 SELL 223.92 SELL
MA_20 224.93 SELL 224 SELL
MA_32 222.29 SELL 223.52 SELL
MA_50 218.97 BUY 223.88 SELL
MA_100 226.86 SELL 223.56 SELL
MA_200 210.69 BUY 210.17 BUY

JAGSNPHARM Trend Oscillators

BUY (1) NEUTRAL (1) SELL (2)
Trend Oscillators Value Action
Bollinger Bands 224.93 Downtrend
MACD -2.19 SELL
ADX 20.53 NO or Weak Trend
DMI (+/-) 31.33 / 23.53 Uptrend

JAGSNPHARM Momentum Oscillators

BUY (1) NEUTRAL (8) SELL (3)
Momentum Oscillators Value Action
RSI 49.27 Neutral
STOCHASTIC_K (Fast) 31.37 Neutral
STOCHASTIC_D (Slow) 14.62 Oversold
CCI -72.3 Neutral
PSAR 259.94 SELL
TRUE RANGE 20.63 Neutral
ATR 15.02 Neutral
WILLIAMS R -68.5 Neutral
TRIX 0 Neutral
STOCHASTIC RSI K 51.34 Neutral
STOCHASTIC RSI D 17.11 Oversold
MOMENTUM 19.15 BUY

JAGSNPHARM Last 1 Year Trend

Duration Value
1 Year 69.51%
3 Months -11.05%
1 Month 9.44%
1 Week -11.16%

JAGSNPHARM Technical Analysis Summary

Updated on 2025-05-12
Action Overall (%)
BUY 23%
NEUTRAL / HOLD 30%
SELL 47%

Most popular Questions & Answers about JAGSNPHARM


Jagsonpal Pharmaceuticals Limited stock last traded price is 232.95. JAGSNPHARM share price moved Down by -0.88% from its previous close of Rs 235.02.

Jagsonpal Pharmaceuticals Limited share price trend is Down with a total of 103057 stocks traded till now. It has touched an intraday high of Rs 331.3204 and an intraday low of Rs 228.83. The JAGSNPHARM trading at 232.95, Down by Rs. -2.07, or -0.88 percent which suggests that most of the Traders are anticipating that the price of JAGSNPHARM share should go Down and the Stop Loss will be around .

The market cap of Jagsonpal Pharmaceuticals Limited is ₹423.1 (in Cr) as of Jun 15, 2025.

The current price to earning ratio for Jagsonpal Pharmaceuticals Limited as of Jun 15, 2025 is 49.72.

The current price to book ratio for Jagsonpal Pharmaceuticals Limited as of Jun 15, 2025 is 3.3.

The highest price of Jagsonpal Pharmaceuticals Limited stock is ₹328.04 in the last 52-week.

The lowest price of Jagsonpal Pharmaceuticals Limited stock is ₹130.48 in the last 52-week.

Jagsonpal Pharmaceuticals Limited share trading at ₹232.95, Down by Rs. -2.07, or -0.88 percent which suggests that most of the traders are anticipating that the price of JAGSNPHARM share should go Down.

In 2025, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹220.8 on downside and ₹329.7 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on current financial year earings of the company.

In 2026, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹329.7 on downside and ₹351.2 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) are ₹351.2 on downside and ₹375.8 on upside. Jagsonpal Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) will be around ₹406 Jagsonpal Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of JAGSNPHARM.

The price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) shares moved by -0.88%. The short-term trend for JAGSNPHARM share price is Down. It implies that the share price of JAGSNPHARM will stay the same tomorrow and that intraday traders should treat VWAP at as a stop loss. Investors with a long-term outlook can track JAGSNPHARM long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of JAGSNPHARM stock is 99.8. Compared to the current market price of 232.95 INR, the JAGSNPHARM stock is Overvalued by 57.2%.

As per the fundamental analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM), it is of Economical quality in terms of earnings and profit margins with an EPS of 8.32. Jagsonpal Pharmaceuticals Limited book value per share as of today is 70.62. The current price to book ratio for JAGSNPHARM as of Jun 16, 2025 is 3.3.


NSE:JAGSNPHARM News & Other Useful Information about JAGSNPHARM Share Price


Peer Comparison of NSE: JAGSNPHARM

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1687.80 17.85 98.33
DIVISLAB 6667.00 83.21 513.62
MEDICAMEQ 412.75 6.97 163.16
CIPLA 1505.20 63.86 360.7
DRREDDY 1362.50 64.1 1452.62
PGHH 5831.00 189.8 373.85
TORNTPHARM 3252.50 55.78 222.38
BIOCON 355.40 5.07 90.7
LUPIN 1999.60 86.99 481.25
ALKEM 4847.50 190.77 984.46
Updated at: 13 Jun 2025 15:50

Feel free to contact us, in case of any queries.

SITEMAP 1523
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2507.90 -35.80 (-1.41%) | ADANIGREEN 989.50 -26.30 (-2.59%) | ADANIPORTS 1405.00 -40.80 (-2.82%) | ADANITRANS 861.00 -15.95 (-1.82%) | AMBUJACEM 542.50 -5.85 (-1.07%) | APOLLOHOSP 6994.50 -2.00 (-0.03%) | ASIANPAINT 2214.20 -5.20 (-0.23%) | ATGL 658.80 -13.95 (-2.07%) | AUROPHARMA 1150.20 -5.00 (-0.43%) | AXISBANK 1205.80 -7.10 (-0.59%) | BAJAJ-AUTO 8463.50 -103.50 (-1.21%) | BAJAJFINSV 2011.00 -17.80 (-0.88%) | BAJFINANCE 9331.00 -37.50 (-0.4%) | BALKRISIND 2463.80 -5.20 (-0.21%) | BANDHANBNK 175.19 -2.49 (-1.4%) | BANKBARODA 239.22 -1.44 (-0.6%) | BEL 394.20 6.80 (1.76%) | BERGEPAINT 570.15 1.60 (0.28%) | BHARTIARTL 1840.40 -3.80 (-0.21%) | BIOCON 355.40 3.15 (0.89%) | BOSCHLTD 31585.00 65.00 (0.21%) | BPCL 312.30 -6.35 (-1.99%) | BRITANNIA 5570.00 0.50 (0.01%) | CADILAHC 974.95 -3.85 (-0.39%) | CIPLA 1505.20 2.40 (0.16%) | COALINDIA 391.20 -1.50 (-0.38%) | COLPAL 2371.20 -35.20 (-1.46%) | DABUR 466.50 -6.45 (-1.36%) | DIVISLAB 6667.00 -58.00 (-0.86%) | DLF 851.25 3.40 (0.4%) | DMART 4051.90 -22.10 (-0.54%) | DRREDDY 1362.50 -0.20 (-0.01%) | EICHERMOT 5319.00 3.50 (0.07%) | GAIL 191.34 -0.84 (-0.44%) | GLAND 1689.70 20.30 (1.22%) | GODREJCP 1188.80 -15.10 (-1.25%) | GRASIM 2663.80 -25.30 (-0.94%) | GUJGASLTD 469.65 -7.55 (-1.58%) | HAVELLS 1541.10 -15.70 (-1.01%) | HCLTECH 1695.30 -5.90 (-0.35%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 4969.20 -62.00 (-1.23%) | HDFCBANK 1917.60 -25.80 (-1.33%) | HDFCLIFE 752.85 -1.65 (-0.22%) | HEROMOTOCO 4333.80 -29.00 (-0.66%) | HINDALCO 641.80 -9.25 (-1.42%) | HINDUNILVR 2319.00 -13.70 (-0.59%) | HINDZINC 514.25 -3.00 (-0.58%) | ICICIBANK 1416.10 -9.10 (-0.64%) | ICICIGI 1940.70 38.80 (2.04%) | ICICIPRULI 629.50 -2.15 (-0.34%) | INDIGO 5262.00 -214.50 (-3.92%) | INDUSINDBK 816.85 -13.05 (-1.57%) | INDUSTOWER 380.35 -2.40 (-0.63%) | INFY 1602.00 -6.60 (-0.41%) | IOB 37.50 -1.04 (-2.7%) | IOC 140.34 -2.65 (-1.85%) | ITC 413.90 -7.10 (-1.69%) | JSWSTEEL 987.25 -8.40 (-0.84%) | KOTAKBANK 2107.40 -19.40 (-0.91%) | LT 3587.40 -16.50 (-0.46%) | LTI 5429.00 14.00 (0.26%) | LUPIN 1999.60 -23.60 (-1.17%) | M&M 3006.00 -13.20 (-0.44%) | MARICO 691.20 -1.25 (-0.18%) | MARUTI 12408.00 18.00 (0.15%) | MCDOWELL-N 1453.10 -32.00 (-2.15%) | MOTHERSUMI 154.01 -1.23 (-0.79%) | MUTHOOTFIN 2598.70 43.70 (1.71%) | NAUKRI 1459.80 -8.60 (-0.59%) | NESTLEIND 2376.80 -8.80 (-0.37%) | NMDC 70.37 -2.05 (-2.83%) | NTPC 331.95 -1.75 (-0.52%) | ONGC 251.51 3.63 (1.46%) | PEL 1132.60 -20.60 (-1.79%) | PIDILITIND 3012.50 -34.40 (-1.13%) | PIIND 3972.60 24.30 (0.62%) | PNB 106.61 -1.41 (-1.31%) | POWERGRID 285.50 -3.50 (-1.21%) | RELIANCE 1427.90 -13.70 (-0.95%) | SAIL 129.35 -0.62 (-0.48%) | SBICARD 1007.00 4.85 (0.48%) | SBILIFE 1755.20 -10.80 (-0.61%) | SBIN 792.35 -13.60 (-1.69%) | SHREECEM 29610.00 -80.00 (-0.27%) | SIEMENS 3260.00 -7.50 (-0.23%) | SRF 3099.60 -6.10 (-0.2%) | SUNPHARMA 1687.80 0.40 (0.02%) | TATACONSUM 1078.40 -6.70 (-0.62%) | TATAMOTORS 712.05 -3.30 (-0.46%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 152.13 -0.76 (-0.5%) | TCS 3445.70 11.50 (0.33%) | TECHM 1659.00 14.60 (0.89%) | TITAN 3421.90 -30.80 (-0.89%) | TORNTPHARM 3252.50 -6.30 (-0.19%) | ULTRACEMCO 11224.00 -99.00 (-0.87%) | UPL 632.50 0.10 (0.02%) | VEDL 458.10 -2.40 (-0.52%) | WIPRO 260.21 0.60 (0.23%) |